Most of the drugs currently used in the treatment of inflammatory diseases, such as NSAIDs, anti-rheumatic drugs, cyclosporine A, and corticosteroids, have inhibitory effects on NF-κB activity [28], providing us with new ideas for the treatment of periodontitis. The gene discussed is NFKB1; the disease is periodontitis.